Insider · CIK 0001810417
Christopher Ryan Sullivan
Files at: AVTX. On EDGAR ↗
Reported trades — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 SForm 4 → | Sep 18, 4:10 pm EDT | Avalo Therapeutics, Inc.AVTX | 12,394 | $16.33 | $202,437 | 39,900 | −23.7% | 10b5-1 |
| Sep 16, 2026 MForm 4 → | Sep 18, 4:10 pm EDT | Avalo Therapeutics, Inc.AVTX | 12,394 | $9.88 | $122,453 | 52,294 | — | 10b5-1 |
| Sep 10, 2026 SForm 4 → | Sep 11, 4:10 pm EDT | Avalo Therapeutics, Inc.AVTX | 10,185 | $17.62 | $179,457 | 39,900 | −20.3% | 10b5-1 |
| Sep 10, 2026 MForm 4 → | Sep 11, 4:10 pm EDT | Avalo Therapeutics, Inc.AVTX | 10,185 | $8.04 | $81,887 | 50,085 | — | 10b5-1 |
| Aug 17, 2026 SForm 4 → | Aug 19, 4:10 pm EDT | Avalo Therapeutics, Inc.AVTX | 72,725 | $19.94 | $1,450,419 | 39,900 | −64.6% | 10b5-1 |
| Aug 17, 2026 MForm 4 → | Aug 19, 4:10 pm EDT | Avalo Therapeutics, Inc.AVTX | 71,852 | $9.88 | $709,898 | 70,931 | — | 10b5-1 |
| Jun 10, 2026 FForm 4 → | Jun 12, 4:36 pm EDT | Avalo Therapeutics, Inc.AVTX | 138 | $13.10 | $1,808 | 40,773 | — |
Reported trades — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 MForm 4 → | Sep 18, 4:10 pm EDT | Avalo Therapeutics, Inc.AVTX | 12,394 | — | — | 83,848 | — | 10b5-1 |
| Sep 10, 2026 MForm 4 → | Sep 11, 4:10 pm EDT | Avalo Therapeutics, Inc.AVTX | 10,185 | — | — | 105,815 | — | 10b5-1 |
| Aug 17, 2026 MForm 4 → | Aug 19, 4:10 pm EDT | Avalo Therapeutics, Inc.AVTX | 71,852 | — | — | 96,242 | — | 10b5-1 |